Archives
Mapping Infarct Structure and Cardiac Electrophysiology
2026-11-13
A proof-of-concept study paired panoramic hyperspectral imaging with optical mapping to examine how epicardial tissue classes relate to electrical activity in infarcted rat hearts. The findings indicate that co-registered structural and electrophysiological maps can reveal spatial patterns around infarct borders, while remaining limited by the ex vivo model, contraction inhibition, and preliminary validation.
What Piribedil Can Show in GPCR Research
2026-11-13
Piribedil is chemically documented as a defined small molecule associated with dopaminergic and GPCR/G protein signaling research. That identity supports a clear framework for interpreting receptor, signaling, and neurological questions, but it does not by itself establish a receptor subtype, agonist or antagonist profile, or disease-related effect.
Adamtsl3, MMP9, and Perineuronal-Net Plasticity
2026-11-12
A mouse visual-cortex study links the schizophrenia-associated glycoprotein Adamtsl3 to perineuronal-net integrity around parvalbumin interneurons. Its genetic, biochemical, pharmacological, and circuit-level findings support MMP9 involvement while remaining limited to preclinical mouse and in-vitro systems.
Mapping Cardiac Structure and Electrical Function
2026-11-12
A proof-of-concept study integrated panoramic hyperspectral imaging with optical mapping to relate epicardial tissue composition to cardiac electrophysiology in infarcted rat hearts. The approach identified infarct and border-zone regions, associated tissue class with action-potential duration, and localized arrhythmia-related activity while highlighting important model and measurement boundaries.
Adamtsl3, MMP9 and Adult Cortical Plasticity
2026-11-11
A mouse visual-cortex study links Adamtsl3 loss in parvalbumin interneurons to perineuronal-net disruption, elevated MMP9 activity, altered inhibition and renewed adult ocular-dominance plasticity. Pharmacological perturbation supports MMP9 involvement, while the findings remain preclinical and model-specific.
Mapping Infarct Structure and Cardiac Electrophysiology
2026-11-11
A proof-of-concept rat-heart study combined panoramic hyperspectral imaging with optical mapping to examine how infarct-related tissue structure corresponds to cardiac electrical activity.
CCR7–Notch1 Crosstalk in Mammary Cancer Stemness
2026-11-10
A preclinical study in MMTV-PyMT mammary tumor cells examined whether CCR7 regulates Notch1 activity and whether this relationship contributes to stemness-associated behavior. The findings support functional pathway crosstalk in the tested model while leaving human disease relevance and clinical translation unresolved.
CCR7–Notch1 Crosstalk in Mammary Cancer Stemness
2026-11-10
A preclinical mouse study supports functional crosstalk between CCR7 and Notch1 in mammary cancer stem-like cells. CCR7 altered Notch1 pathway activation and downstream stemness-associated behavior without substantially changing surface receptor abundance, while Notch inhibition weakened ligand-linked responses. The findings remain model-specific and mechanistic rather than clinical.
NHE1, Olfr2 and Octanal in Atherosclerosis
2026-11-09
A preclinical study links octanal/Olfr2 signaling with NHE1 activity in macrophages, calcium- and ROS-associated responses, foam-cell formation, and atherosclerotic lesion severity. Convergent pharmacologic, genetic, and gene-silencing observations support a pathway model, while the order of calcium, ROS, and NHE1 events remains unresolved.
How Leukadherin 1 Changes Inflammatory Trafficking
2026-11-09
Leukadherin 1 is described as a CD11b/CD18 activator that strengthens integrin-dependent adhesion, yet documented models show reduced neutrophil accumulation and inflammatory tissue injury. The key interpretation is that adhesion affects several stages of immune-cell trafficking, so stronger receptor–ligand engagement does not automatically mean greater tissue accumulation.
How BIS-TRIS Shapes pH-Sensitive Readouts
2026-11-08
BIS-TRIS is best understood as a pH-control component whose protonatable amine can moderate changes in hydrogen-ion activity. That molecular role can influence protein charge, electrophoretic migration, enzyme measurements, and cellular responses, but the documented information supports mechanism and intended research contexts rather than application-specific performance outcomes.
CCR7–Notch1 Crosstalk in Mammary Tumor Stemness
2026-11-07
A preclinical mammary-tumor study examined whether CCR7 and Notch1 interact functionally in stem-like cancer cells. Its results support a model in which CCR7 signaling enhances Notch activity and Notch contributes to CCR7-associated stemness behavior, while leaving broader biological generalization unresolved.
How Aliskiren Connects Renin to Blood Pressure
2026-11-06
Aliskiren provides a mechanism-level way to interpret renin-angiotensin-aldosterone system inhibition, while distinguishing enzyme, hormonal and cardiovascular readouts that do not necessarily change in parallel.
NHE1, Olfr2 and Octanal-Linked Atherosclerosis
2026-11-06
A mouse and macrophage study supports a preclinical pathway model in which octanal-associated Olfr2 signaling engages NHE1, with linked calcium, oxidative, inflammatory and foam-cell responses. The evidence is mechanistically convergent but remains bounded by the models and by unresolved causal ordering between calcium signaling, ROS and NHE1.
NHE1, Octanal and Atherosclerotic Inflammation
2026-11-05
A mouse-and-macrophage study links octanal/Olfr2 signaling with NHE1 activation, altered calcium- and ROS-associated responses, foam-cell formation, and inflammatory markers. Genetic and pharmacologic perturbations support pathway involvement, while the model-specific design leaves the precise molecular sequence unresolved.